175 related articles for article (PubMed ID: 12041781)
21. Meta-analysis of bacterial resistance to macrolides.
Halpern MT; Schmier JK; Snyder LM; Asche C; Sarocco PW; Lavin B; Nieman R; Mandell LA
J Antimicrob Chemother; 2005 May; 55(5):748-57. PubMed ID: 15772147
[TBL] [Abstract][Full Text] [Related]
22. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan.
Hsueh PR; Shyr JM; Wu JJ
Clin Microbiol Infect; 2006 Mar; 12(3):296-8. PubMed ID: 16451421
[TBL] [Abstract][Full Text] [Related]
23. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.
Sakran W; Raz R; Chazan B; Koren A; Colodner R
Int J Antimicrob Agents; 2004 May; 23(5):517-9. PubMed ID: 15120735
[TBL] [Abstract][Full Text] [Related]
24. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antibacterial activity of 6-O-arylbutynyl ketolides with improved activity against some key erythromycin-resistant pathogens.
Keyes RF; Carter JJ; Englund EE; Daly MM; Stone GG; Nilius AM; Ma Z
J Med Chem; 2003 May; 46(10):1795-8. PubMed ID: 12723941
[TBL] [Abstract][Full Text] [Related]
26. Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004).
Cantón R; Unal S; Farrell DJ
Int J Antimicrob Agents; 2007 Dec; 30(6):546-50. PubMed ID: 17931834
[TBL] [Abstract][Full Text] [Related]
27. Roxithromycin--a new macrolide derivative.
Hejzlar M; Novotný F; Stastná L; Dvorák M; Kittnar E; Sedmidubský V
J Hyg Epidemiol Microbiol Immunol; 1989; 33(4):487-93. PubMed ID: 2696762
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
29. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
[TBL] [Abstract][Full Text] [Related]
30. In-vitro activity of roxithromycin against Chlamydia trachomatis.
Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
[TBL] [Abstract][Full Text] [Related]
31. Loss of erythromycin resistance genes from strains of Streptococcus pyogenes that have developed resistance to levofloxacin.
Billal DS; Hotomi M; Yan SS; Fedorko DP; Shimada J; Fujihara K; Yamanaka N
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):225-8. PubMed ID: 19345038
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of roxithromycin against Moraxella catarrhalis.
Spencer RC; Wheat PF
Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):63S-65S. PubMed ID: 1617926
[TBL] [Abstract][Full Text] [Related]
33. Comparative Emergence of Resistance to Clofoctol, Erythromycin, and Amoxicillin against Community-Acquired Bacterial Respiratory Tract Pathogens in Italy.
Scaglione F; Lucini V; Dugnani S; Pani A
Chemotherapy; 2018; 63(6):330-337. PubMed ID: 30909281
[TBL] [Abstract][Full Text] [Related]
34. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
Song JH; Chang HH; Suh JY; Ko KS; Jung SI; Oh WS; Peck KR; Lee NY; Yang Y; Chongthaleong A; Aswapokee N; Chiu CH; Lalitha MK; Perera J; Yee TT; Kumararasinghe G; Jamal F; Kamarulazaman A; Parasakthi N; Van PH; So T; Ng TK;
J Antimicrob Chemother; 2004 Mar; 53(3):457-63. PubMed ID: 14963068
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
Brown SD; Rybak MJ
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
Crotti D; Rossetti R; Braga PC
Drugs Exp Clin Res; 2004; 30(1):17-26. PubMed ID: 15134387
[TBL] [Abstract][Full Text] [Related]
37. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
Koh EH; Kim S; Lee NY
Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
[TBL] [Abstract][Full Text] [Related]
38. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
39. [On some characteristics of staphylococci isolated from the sputum before and after therapy with erythromycin].
Lo Curto RB; Pernice A; Alonzo V
G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):269-75. PubMed ID: 4802277
[No Abstract] [Full Text] [Related]
40. Synthesis and antibacterial activity of novel bifunctional macrolides.
Akritopoulou-Zanze I; Phelan KM; Marron TG; Yong H; Ma Z; Stone GG; Daly MM; Hensey DM; Nilius AM; Djuric SW
Bioorg Med Chem Lett; 2004 Jul; 14(14):3809-13. PubMed ID: 15203167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
